| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-18 | 2009-09-30 | 13F-HR | Jane Street Holding Llc | Institution | 25,792 | Added More | 400 | 1.57 % | $260,499 | $258,178 | $-2,321 | -0.89 % | $-36 | | | | | | News Article | History of Jane Street Holding Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Amvescap Plc | Institution | 849,161 | New Holding | 849,161 | 100 % | $8,771,833 | $8,500,102 | $-271,732 | -3.09 % | $-271,732 | | | | | | News Article | History of Amvescap Plc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Credit Suisse First Boston | Institution | | Sold All | -64,186 | -100 % | | | | -3.09 % | $20,540 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | American International Group Inc | Institution | 28,007 | No Change | 0 | 0 % | $308,917 | $280,350 | $-28,567 | -9.24 % | $0 | | | | | | News Article | History of American International Group Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Black River Asset Management Llc | Institution | 15,400 | New Holding | 15,400 | 100 % | $169,862 | $154,154 | $-15,708 | -9.24 % | $-15,708 | | | | | | News Article | History of Black River Asset Management Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bridger Management Llc | Institution | 346,550 | New Holding | 346,550 | 100 % | $3,822,447 | $3,468,966 | $-353,481 | -9.24 % | $-353,481 | | | | | | News Article | History of Bridger Management Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | 336,376 | New Holding | 336,376 | 100 % | $3,710,227 | $3,367,124 | $-343,104 | -9.24 % | $-343,104 | | | | | | News Article | History of Citadel L P Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Dafna Capital Management Llc | Institution | 101,402 | Sold Some | -234,998 | -69.85 % | $1,118,464 | $1,015,034 | $-103,430 | -9.24 % | $239,698 | | | | | | News Article | History of Dafna Capital Management Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Driehaus Capital Management Llc | Institution | 158,230 | New Holding | 158,230 | 100 % | $1,745,277 | $1,583,882 | $-161,395 | -9.24 % | $-161,395 | | | | | | News Article | History of Driehaus Capital Management Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fmr Corp | Institution | 402,155 | New Holding | 402,155 | 100 % | $4,435,770 | $4,025,572 | $-410,198 | -9.24 % | $-410,198 | | | | | | News Article | History of Fmr Corp Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Galleon Management L P | Institution | 30,000 | New Holding | 30,000 | 100 % | $330,900 | $300,300 | $-30,600 | -9.24 % | $-30,600 | | | | | | News Article | History of Galleon Management L P Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ing Groep Nv | Institution | 13,250 | Added More | 2,950 | 28.64 % | $146,148 | $132,633 | $-13,515 | -9.24 % | $-3,009 | | | | | | News Article | History of Ing Groep Nv Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Millennium Management Llc | Institution | 223,672 | Added More | 15,746 | 7.57 % | $2,467,102 | $2,238,957 | $-228,145 | -9.24 % | $-16,061 | | | | | | News Article | History of Millennium Management Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 50,156 | New Holding | 50,156 | 100 % | $553,221 | $502,062 | $-51,159 | -9.24 % | $-51,159 | | | | | | News Article | History of Morgan Stanley Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 394,154 | Added More | 240,074 | 155.81 % | $4,347,519 | $3,945,482 | $-402,037 | -9.24 % | $-244,875 | | | | | | News Article | History of Northern Trust Corp Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Oppenheimer Funds Inc | Institution | | Sold All | -4,170 | -100 % | | | | -9.24 % | $4,253 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Palo Alto Investors Llc | Institution | 343,933 | Added More | 123,785 | 56.22 % | $3,793,581 | $3,442,769 | $-350,812 | -9.24 % | $-126,261 | | | | | | News Article | History of Palo Alto Investors Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Teleos Management Llc | Institution | 10,000 | New Holding | 10,000 | 100 % | $110,300 | $100,100 | $-10,200 | -9.24 % | $-10,200 | | | | | | News Article | History of Teleos Management Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Us Bancorp De | Institution | 2,512 | No Change | 0 | 0 % | $27,707 | $25,145 | $-2,562 | -9.24 % | $0 | | | | | | News Article | History of Us Bancorp De Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wellington Management Co Llp | Institution | 76,850 | No Change | 0 | 0 % | $847,656 | $769,269 | $-78,387 | -9.24 % | $0 | | | | | | News Article | History of Wellington Management Co Llp Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | 2,000 | New Holding | 2,000 | 100 % | $21,420 | $20,020 | $-1,400 | -6.53 % | $-1,400 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Axa | Institution | 716,340 | Added More | 566,318 | 377.48 % | $7,672,001 | $7,170,563 | $-501,438 | -6.53 % | $-396,423 | | | | | | News Article | History of Axa Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 2,469 | Added More | 2,210 | 853.28 % | $26,443 | $24,715 | $-1,728 | -6.53 % | $-1,547 | | | | | | News Article | History of Barclays Plc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bnp Paribas Arbitrage Sa | Institution | 12,126 | New Holding | 12,126 | 100 % | $129,869 | $121,381 | $-8,488 | -6.53 % | $-8,488 | | | | | | News Article | History of Bnp Paribas Arbitrage Sa Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Credit Agricole S A | Institution | 2,460 | New Holding | 2,460 | 100 % | $26,347 | $24,625 | $-1,722 | -6.53 % | $-1,722 | | | | | | News Article | History of Credit Agricole S A Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Dekabank Deutsche Girozentrale | No Data | 206,886 | No Change | 0 | 0 % | $2,215,749 | $2,070,929 | $-144,820 | -6.53 % | $0 | | | | | | News Article | History of Dekabank Deutsche Girozentrale Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Gartmore Mutual Fund Capital Trust | Institution | 292 | Sold Some | -27,018 | -98.93 % | $3,127 | $2,923 | $-204 | -6.53 % | $18,913 | | | | | | News Article | History of Gartmore Mutual Fund Capital Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 14,084 | Added More | 2,186 | 18.37 % | $150,840 | $140,981 | $-9,859 | -6.53 % | $-1,530 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Jacobs Levy Equity Management Inc | Institution | | Sold All | -26,510 | -100 % | | | | -6.53 % | $18,557 | | | | | | News Article | History of Jacobs Levy Equity Management Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Capital Markets Arbitrage S A | Institution | 600 | New Holding | 600 | 100 % | $6,426 | $6,006 | $-420 | -6.53 % | $-420 | | | | | | News Article | History of Rbc Capital Markets Arbitrage S A Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 26,176 | New Holding | 26,176 | 100 % | $280,345 | $262,022 | $-18,323 | -6.53 % | $-18,323 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Renaissance Technologies Corp | Institution | | Sold All | -26,100 | -100 % | | | | -6.53 % | $18,270 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 31,579 | Added More | 1,400 | 4.63 % | $338,211 | $316,106 | $-22,105 | -6.53 % | $-980 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 1,321,431 | Added More | 144,205 | 12.24 % | $13,544,668 | $13,227,524 | $-317,143 | -2.34 % | $-34,609 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Ing Investment Management Co | Institution | 13,050 | Added More | 2,750 | 26.69 % | $133,763 | $130,631 | $-3,132 | -2.34 % | $-660 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 200 | Sold Some | -5,750 | -96.63 % | $2,050 | $2,002 | $-48 | -2.34 % | $1,380 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mfc Global Investment Management Usa Ltd | Institution | 29,870 | Added More | 2,224 | 8.04 % | $306,168 | $298,999 | $-7,169 | -2.34 % | $-534 | | | | | | News Article | History of Mfc Global Investment Management Usa Ltd Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 1,215 | Added More | 77 | 6.76 % | $12,454 | $12,162 | $-292 | -2.34 % | $-18 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Inc | Institution | 1,541 | Added More | 623 | 67.86 % | $15,795 | $15,425 | $-370 | -2.34 % | $-150 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | | Sold All | -163,193 | -100 % | | | | -2.34 % | $39,166 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Technical Financial Services Llc | Institution | 92,458 | New Holding | 92,458 | 100 % | $947,695 | $925,505 | $-22,190 | -2.34 % | $-22,190 | | | | | | News Article | History of Technical Financial Services Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Alphabet Management Llc | No Data | 76,300 | Added More | 6,400 | 9.15 % | $910,259 | $763,763 | $-146,496 | -16.09 % | $-12,288 | | | | | | News Article | History of Alphabet Management Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | J P Morgan Chase And Co | Institution | 344,183 | Sold Some | -120,597 | -25.94 % | $4,106,103 | $3,445,272 | $-660,831 | -16.09 % | $231,546 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 1,370 | New Holding | 1,370 | 100 % | $16,344 | $13,714 | $-2,630 | -16.09 % | $-2,630 | | | | | | News Article | History of Ubs Ag Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Federated Investors Inc | Institution | 1,857,283 | Sold Some | -248,575 | -11.80 % | $22,547,416 | $18,591,403 | $-3,956,013 | -17.54 % | $529,465 | | | | | | News Article | History of Federated Investors Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Numeric Investors Llc | Institution | 412,447 | New Holding | 412,447 | 100 % | $5,007,107 | $4,128,594 | $-878,512 | -17.54 % | $-878,512 | | | | | | News Article | History of Numeric Investors Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metropolitan Life Insurance Co | Institution | 33,551 | No Change | 0 | 0 % | $393,218 | $335,846 | $-57,372 | -14.59 % | $0 | | | | | | News Article | History of Metropolitan Life Insurance Co Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pnc Financial Services Group Inc | Institution | | Sold All | -589 | -100 % | | | | -14.59 % | $1,007 | | | | | | News Article | History of Pnc Financial Services Group Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 30,329 | No Change | 0 | 0 % | $355,456 | $303,593 | $-51,863 | -14.59 % | $0 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 309,953 | Added More | 90,000 | 40.91 % | $3,632,649 | $3,102,630 | $-530,020 | -14.59 % | $-153,900 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-06 | 2009-08-31 | N-CSR | Valic Co Ii - Small Cap Value Fund | Small-Cap Value | | Sold All | -37,400 | -100 % | | | | -14.59 % | $63,954 | | | | | | News Article | History of Valic Co Ii - Small Cap Value Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Proshare Advisors Llc | Institution | | Sold All | -13,588 | -100 % | | | | -13.70 % | $21,605 | | | | | | News Article | History of Proshare Advisors Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Turner Investment Partners Inc | Institution | 59,280 | New Holding | 59,280 | 100 % | $635,482 | $593,393 | $-42,089 | -6.62 % | $-42,089 | | | | | | News Article | History of Turner Investment Partners Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Pharmaceuticals Portfolio | Health/Biotech | 3,000 | New Holding | 3,000 | 100 % | $31,290 | $30,030 | $-1,260 | -4.02 % | $-1,260 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Oxford Asset Management | Institution | 40,711 | New Holding | 40,711 | 100 % | $385,940 | $407,517 | $21,577 | 5.59 % | $21,577 | | | | | | News Article | History of Oxford Asset Management Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Cornerstone Strategy Fund | Specialty & Misc | 2,900 | Added More | 2,300 | 383.33 % | $27,956 | $29,029 | $1,073 | 3.83 % | $851 | | | | | | News Article | History of Usaa Mutual Funds Trust - Cornerstone Strategy Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Growth Fund | Multi-Cap Growth | | Sold All | -700 | -100 % | | | | 3.83 % | $-259 | | | | | | News Article | History of Usaa Mutual Funds Trust - Growth Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Small Cap Index Fund | Small-Cap Core | 28,007 | New Holding | 28,007 | 100 % | $269,987 | $280,350 | $10,363 | 3.83 % | $10,363 | | | | | | News Article | History of Valic Co I - Small Cap Index Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Essex Investment Management Co Llc | Institution | 3,938 | Sold Some | -2,269 | -36.55 % | $36,545 | $39,419 | $2,875 | 7.86 % | $-1,656 | | | | | | News Article | History of Essex Investment Management Co Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Magee Thomson Investment Partners Llc | Institution | 10,590 | New Holding | 10,590 | 100 % | $89,380 | $106,006 | $16,626 | 18.60 % | $16,626 | | | | | | News Article | History of Magee Thomson Investment Partners Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | | Sold All | -1,300 | -100 % | | | | 14.40 % | $-1,638 | | | | | | News Article | History of Blackrock Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 44,388 | Sold Some | -5,596 | -11.19 % | $388,395 | $444,324 | $55,929 | 14.40 % | $-7,051 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 73,571 | Sold Some | -8,779 | -10.66 % | $671,703 | $736,446 | $64,742 | 9.63 % | $-7,726 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | State Board Of Administration Of Florida Retirement System | Institution | 17,048 | New Holding | 17,048 | 100 % | $155,648 | $170,650 | $15,002 | 9.63 % | $15,002 | | | | | | News Article | History of State Board Of Administration Of Florida Retirement System Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Strs Ohio | Institution | 18,000 | Sold Some | -17,800 | -49.72 % | $170,640 | $180,180 | $9,540 | 5.59 % | $-9,434 | | | | | | News Article | History of Strs Ohio Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Public Employees Retirement System Of Ohio | Institution | 42,201 | No Change | 0 | 0 % | $395,423 | $422,432 | $27,009 | 6.83 % | $0 | | | | | | News Article | History of Public Employees Retirement System Of Ohio Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-08 | 2009-09-30 | 13F-HR | Rhumbline Advisers | Institution | 44,673 | Sold Some | -1,600 | -3.45 % | $408,311 | $447,177 | $38,866 | 9.51 % | $-1,392 | | | | | | News Article | History of Rhumbline Advisers Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Alliancebernstein Cap Fund Inc - Alliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 43,000 | New Holding | 43,000 | 100 % | $348,300 | $430,430 | $82,130 | 23.58 % | $82,130 | | | | | | News Article | History of Alliancebernstein Cap Fund Inc - Alliancebernstein Small Cap Growth Portfolio Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Growth Fund | Multi-Cap Growth | 700 | New Holding | 700 | 100 % | $5,670 | $7,007 | $1,337 | 23.58 % | $1,337 | | | | | | News Article | History of Usaa Mutual Funds Trust - Growth Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund | Small-Cap Core | | Sold All | -100 | -100 % | | | | 23.12 % | $-188 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund | Small-Cap Core | | Sold All | -100 | -100 % | | | | 23.12 % | $-188 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-17 | 2009-07-31 | N-Q | Rydex Etf Trust - Rydex Inverse Russell 2000 Etf | Specialty & Misc | 740 | New Holding | 740 | 100 % | $5,402 | $7,407 | $2,005 | 37.12 % | $2,005 | | | | | | News Article | History of Rydex Etf Trust - Rydex Inverse Russell 2000 Etf Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 1,177,226 | Added More | 856,208 | 266.71 % | $8,664,383 | $11,784,032 | $3,119,649 | 36.00 % | $2,268,951 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Series Funds - Banking Fund | Financial Services | 918 | Added More | 587 | 177.34 % | $6,968 | $9,189 | $2,222 | 31.88 % | $1,421 | | | | | | News Article | History of Rydex Series Funds - Banking Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust - Biotechnology Fund | Health/Biotech | 448 | Added More | 358 | 397.77 % | $3,400 | $4,484 | $1,084 | 31.88 % | $866 | | | | | | News Article | History of Rydex Variable Trust - Biotechnology Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Advanced Series Trust - Ast Federated Aggressive Growth Portfolio | Multi-Cap Growth | | Sold All | -75,427 | -100 % | | | | 35.63 % | $-198,373 | | | | | | News Article | History of Advanced Series Trust - Ast Federated Aggressive Growth Portfolio Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Advanced Series Trust - Ast International Value Portfolio | Multi-Cap Value | | Sold All | -10,800 | -100 % | | | | 35.63 % | $-28,404 | | | | | | News Article | History of Advanced Series Trust - Ast International Value Portfolio Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio | Small-Cap Growth | | Sold All | -7,500 | -100 % | | | | 35.63 % | $-19,725 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 40,900 | No Change | 0 | 0 % | $301,842 | $409,409 | $107,567 | 35.63 % | $0 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Value Portfolio | Multi-Cap Value | 5,800 | New Holding | 5,800 | 100 % | $42,804 | $58,058 | $15,254 | 35.63 % | $15,254 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Value Portfolio Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqbond Index Portfolio | Specialty & Misc | 99,922 | Sold Some | -19,178 | -16.10 % | $737,424 | $1,000,219 | $262,795 | 35.63 % | $-50,438 | | | | | | News Article | History of Eq Advisors Trust - Eqbond Index Portfolio Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I - Jpmorgan Japan Fund | Japanese | | Sold All | -31 | -100 % | | | | 35.63 % | $-82 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Japan Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I - Jpmorgan Small Cap Core Fund | Small-Cap Core | | Sold All | -114 | -100 % | | | | 35.63 % | $-300 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Small Cap Core Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust Ii - Jpmorgan Small Cap Value Fund | Small-Cap Value | | Sold All | -51 | -100 % | | | | 35.63 % | $-134 | | | | | | News Article | History of Jpmorgan Trust Ii - Jpmorgan Small Cap Value Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 160 | New Holding | 160 | 100 % | $1,181 | $1,602 | $421 | 35.63 % | $421 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund Ii - Mml Small Cap Equity Fund | Small-Cap Core | 100 | New Holding | 100 | 100 % | $757 | $1,001 | $244 | 32.23 % | $244 | | | | | | News Article | History of Mml Series Investment Fund Ii - Mml Small Cap Equity Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pd Small-Cap Growth Index Portfolio | No Data | 559 | No Compare | | | $4,232 | $5,596 | $1,364 | 32.23 % | | | | | | | News Article | History of Pacific Select Fund - Pd Small-Cap Growth Index Portfolio Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund - Stock Index Fund | Specialty & Misc | 431 | New Holding | 431 | 100 % | $2,758 | $4,314 | $1,556 | 56.40 % | $1,556 | | | | | | News Article | History of Tiaa Cref Life Fund - Stock Index Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-CSR | Allianz Funds - Occ Value | Large-Cap Value | 53,545 | Sold Some | -123,895 | -69.82 % | $320,199 | $535,985 | $215,786 | 67.39 % | $-499,297 | | | | | | News Article | History of Allianz Funds - Occ Value Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Growth Index Fund | Multi-Cap Growth | 247,943 | Added More | 176,847 | 248.74 % | $1,482,699 | $2,481,909 | $999,210 | 67.39 % | $712,693 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Growth Index Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Index Fund | Specialty & Misc | 423,354 | Added More | 293,436 | 225.86 % | $2,531,657 | $4,237,774 | $1,706,117 | 67.39 % | $1,182,547 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Index Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | 2,181 | Added More | 1,100 | 101.75 % | $13,042 | $21,832 | $8,789 | 67.39 % | $4,433 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Growth Index Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Index Fund | Specialty & Misc | 8,637 | Added More | 7,930 | 1121.64 % | $51,649 | $86,456 | $34,807 | 67.39 % | $31,958 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Index Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Microcap Index Fund | Specialty & Misc | 54,443 | New Holding | 54,443 | 100 % | $325,569 | $544,974 | $219,405 | 67.39 % | $219,405 | | | | | | News Article | History of Ishares Trust - Ishares Russell Microcap Index Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Equity Index Fund | Specialty & Misc | 23,338 | Added More | 20,670 | 774.73 % | $141,428 | $233,613 | $92,185 | 65.18 % | $81,647 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Equity Index Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Growth Equity Fund | Multi-Cap Growth | | Sold All | -4,567 | -100 % | | | | 65.18 % | $-18,040 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Growth Equity Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-24 | 2009-06-30 | N-CSRS | Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva | Specialty & Misc | 700 | New Holding | 700 | 100 % | $4,186 | $7,007 | $2,821 | 67.39 % | $2,821 | | | | | | News Article | History of Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-21 | 4 | Frost Gamma Investment Trust | Insider | 8,516,913 | Sold Some | -2,100 | -0.02 % | $51,697,662 | $85,254,299 | $33,556,637 | 64.90 % | $-8,274 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-21 | 4 | Frost Gamma Investment Trust | Insider | 8,531,213 | Sold Some | -700 | 0.00 % | $51,784,463 | $85,397,442 | $33,612,979 | 64.90 % | $-2,758 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-21 | 4 | Frost Gamma Investment Trust | Insider | 8,519,013 | Sold Some | -12,200 | -0.14 % | $51,710,409 | $85,275,320 | $33,564,911 | 64.90 % | $-48,068 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-21 | 4 | Frost Phillip Md Et Al | Insider | 8,516,913 | Sold Some | -2,100 | -0.02 % | $51,697,662 | $85,254,299 | $33,556,637 | 64.90 % | $-8,274 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-21 | 4 | Frost Phillip Md Et Al | Insider | 8,531,213 | Sold Some | -700 | 0.00 % | $51,784,463 | $85,397,442 | $33,612,979 | 64.90 % | $-2,758 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-21 | 4 | Frost Phillip Md Et Al | Insider | 8,519,013 | Sold Some | -12,200 | -0.14 % | $51,710,409 | $85,275,320 | $33,564,911 | 64.90 % | $-48,068 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Gamma Investment Trust | Insider | 8,538,095 | Sold Some | -4,280 | -0.05 % | $51,826,237 | $85,466,331 | $33,640,094 | 64.90 % | $-16,863 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Gamma Investment Trust | Insider | 8,531,913 | Sold Some | -6,182 | -0.07 % | $51,788,712 | $85,404,449 | $33,615,737 | 64.90 % | $-24,357 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Gamma Investment Trust | Insider | 8,628,455 | Sold Some | -3,458 | -0.04 % | $52,374,722 | $86,370,835 | $33,996,113 | 64.90 % | $-13,625 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Gamma Investment Trust | Insider | 8,596,634 | Sold Some | -31,821 | -0.36 % | $52,181,568 | $86,052,306 | $33,870,738 | 64.90 % | $-125,375 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Gamma Investment Trust | Insider | 8,595,906 | Sold Some | -728 | 0.00 % | $52,177,149 | $86,045,019 | $33,867,870 | 64.90 % | $-2,868 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Gamma Investment Trust | Insider | 8,591,356 | Sold Some | -4,550 | -0.05 % | $52,149,531 | $85,999,474 | $33,849,943 | 64.90 % | $-17,927 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Gamma Investment Trust | Insider | 8,545,325 | Sold Some | -46,031 | -0.53 % | $51,870,123 | $85,538,703 | $33,668,581 | 64.90 % | $-181,362 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Gamma Investment Trust | Insider | 8,542,466 | Sold Some | -2,859 | -0.03 % | $51,852,769 | $85,510,085 | $33,657,316 | 64.90 % | $-11,264 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Gamma Investment Trust | Insider | 8,542,375 | Sold Some | -91 | 0.00 % | $51,852,216 | $85,509,174 | $33,656,958 | 64.90 % | $-359 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Phillip Md Et Al | Insider | 8,596,634 | Sold Some | -31,821 | -0.36 % | $52,181,568 | $86,052,306 | $33,870,738 | 64.90 % | $-125,375 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Phillip Md Et Al | Insider | 8,628,455 | Sold Some | -3,458 | -0.04 % | $52,374,722 | $86,370,835 | $33,996,113 | 64.90 % | $-13,625 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Phillip Md Et Al | Insider | 8,545,325 | Sold Some | -46,031 | -0.53 % | $51,870,123 | $85,538,703 | $33,668,581 | 64.90 % | $-181,362 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Phillip Md Et Al | Insider | 8,542,466 | Sold Some | -2,859 | -0.03 % | $51,852,769 | $85,510,085 | $33,657,316 | 64.90 % | $-11,264 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Phillip Md Et Al | Insider | 8,542,375 | Sold Some | -91 | 0.00 % | $51,852,216 | $85,509,174 | $33,656,958 | 64.90 % | $-359 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Phillip Md Et Al | Insider | 8,538,095 | Sold Some | -4,280 | -0.05 % | $51,826,237 | $85,466,331 | $33,640,094 | 64.90 % | $-16,863 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Phillip Md Et Al | Insider | 8,531,913 | Sold Some | -6,182 | -0.07 % | $51,788,712 | $85,404,449 | $33,615,737 | 64.90 % | $-24,357 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Phillip Md Et Al | Insider | 8,591,356 | Sold Some | -4,550 | -0.05 % | $52,149,531 | $85,999,474 | $33,849,943 | 64.90 % | $-17,927 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Phillip Md Et Al | Insider | 8,595,906 | Sold Some | -728 | 0.00 % | $52,177,149 | $86,045,019 | $33,867,870 | 64.90 % | $-2,868 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
RSS feed for PLX